+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Rickets Treatment Market 2019-2023 - Product Image

Global Rickets Treatment Market 2019-2023

  • ID: 4769643
  • Report
  • Region: Global
  • 119 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • MORE
About this market

The growing awareness about vitamin D deficiency is one of the key factors expected to trigger market growth in the upcoming years. Rickets is often caused due to vitamin D deficiency in the body due to less exposure to the sun, dark skin, and the lack of vitamin D in the diet. Several programs are being initiated for creating public awareness about the health issues associated with vitamin D deficiency including rickets. Such rising awareness programs are further expected to boost the global rickets treatment market growth during the forecast period. The analysts have predicted that the rickets treatment market will register a CAGR of nearly 6% by 2023.

Market Overview

Growing awareness about vitamin D deficiency

The increasing number of awareness programs are leading to the increasing diagnosis of the conditions caused by the deficiency of vitamin D, which, in turn, leading to the increasing use of supplements and drugs for the treatment.

Availability of substitute treatment options

Alternative therapies have a higher perceived value than the drugs, thereby the availability of substitute treatment options acts as a challenge to the growth of the global rickets treatment market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the rickets treatment market during 2019-2023, view the full report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. The advent of biologics is encouraging companies to develop biological therapies, especially for the treatment of rare diseases. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY TYPE
  • Market segmentation by type
  • Comparison by type
  • Vitamin D-related rickets - Market size and forecast 2018-2023
  • Minerals-related rickets - Market size and forecast 2018-2023
  • Market opportunity by type
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of vendors classification
List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Type - Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Vitamin D-related rickets - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Vitamin D-related rickets - Year-over-year growth 2019-2023 (%)
Exhibit 21: Minerals-related rickets - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Minerals-related rickets - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by type
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Top 3 countries in North America
Exhibit 30: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in Asia
Exhibit 33: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in ROW
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Strategic alliances in global rickets treatment market
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: F. Hoffmann-La Roche Ltd - Vendor overview
Exhibit 49: F. Hoffmann-La Roche Ltd - Product segments
Exhibit 50: F. Hoffmann-La Roche Ltd - Organizational developments
Exhibit 51: F. Hoffmann-La Roche Ltd - Geographic focus
Exhibit 52: F. Hoffmann-La Roche Ltd - Segment focus
Exhibit 53: F. Hoffmann-La Roche Ltd - Key offerings
Exhibit 54: F. Hoffmann-La Roche Ltd - Key customers
Exhibit 55: Merck KGaA - Vendor overview
Exhibit 56: Merck KGaA - Business segments
Exhibit 57: Merck KGaA - Organizational developments
Exhibit 58: Merck KGaA - Geographic focus
Exhibit 59: Merck KGaA - Segment focus
Exhibit 60: Merck KGaA - Key offerings
Exhibit 61: Merck KGaA - Key customers
Exhibit 62: Novartis AG - Vendor overview
Exhibit 63: Novartis AG - Business segments
Exhibit 64: Novartis AG - Organizational developments
Exhibit 65: Novartis AG - Geographic focus
Exhibit 66: Novartis AG - Segment focus
Exhibit 67: Novartis AG - Key offerings
Exhibit 68: Novartis AG - Key customers
Exhibit 69: Pfizer Inc. - Vendor overview
Exhibit 70: Pfizer Inc. - Business segments
Exhibit 71: Pfizer Inc. - Organizational developments
Exhibit 72: Pfizer Inc. - Geographic focus
Exhibit 73: Pfizer Inc. - Segment focus
Exhibit 74: Pfizer Inc. - Key offerings
Exhibit 75: Pfizer Inc. - Key customers
Exhibit 76: Sanofi - Vendor overview
Exhibit 77: Sanofi - Business segments
Exhibit 78: Sanofi - Organizational developments
Exhibit 79: Sanofi - Geographic focus
Exhibit 80: Sanofi - Segment focus
Exhibit 81: Sanofi - Key offerings
Exhibit 82: Sanofi - Key customers
Exhibit 83: Validation techniques employed for market sizing
Exhibit 84: Definition of vendors classification
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • MORE
Global Rickets Treatment Market 2019-2023

The analyst recognizes the following companies as the key players in the global rickets treatment market: F. Hoffmann-La Roche Ltd, Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the growing use of e-commerce.”

According to the report, one of the major drivers for this market is the strategic alliance.

Further, the report states that one of the major factors hindering the growth of this market is the availability of substitute treatment options.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769643
Adroll
adroll